Serotonin Signaling in Cancer Development and Progression

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Biomacromolecules: Proteins, Nucleic Acids and Carbohydrates".

Deadline for manuscript submissions: 30 October 2026 | Viewed by 20

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, Hungary
Interests: cancer prevention; serotonin; drug synergy; retinoid biology

Special Issue Information

Dear Colleagues,

Serotonin (5-hydroxytryptamine) is both a neurohormone and neurotransmitter, modulating mood, memory, circadian cycle and behavior, as well as respiratory and thermoregulatory networks. As monoaminergic mediators have emerged as critical factors in diverse signaling events across all organs and tissues, it has become clear that serotonin too has a far broader scope of functions outside the nervous system. While serotonin-related physiological functions include platelet activation, gastrointestinal homeostasis, microbial-host crosstalk, lactation and mammary gland involution, the role of autocrine and paracrine effects of serotonin on carcinogenesis, tumor maintenance and progression remain largely unresolved. The complexity of its biological action is partially explained by the fact that serotonin can interact with 14 dedicated receptors. Moreover, serotonin signaling is further complicated by differential receptor expression across all tissues, and recent notions of non-cell surface localizations that are linked to distinct biological consequences. Furthermore, the potential of serotonin to modulate the activity of select target proteins through posttranslational modification leaves many unanswered questions. The successful targeting of the production, breakdown or uptake of serotonin through dedicated transporters by novel or commonly used pharmacological agents could therefore have a large medicinal impact.

The focus of this Special Issue is on the contribution of serotonin signaling at any level to the pathogenesis of cancers. We invite both original research and review articles relevant to this topic. We particularly encourage the submission of basic research that advances knowledge of serotonin’s contribution to cancer-related metabolic changes. Research areas may include (but are not limited to) the epigenetic modulation of gene expression, mechanosensory processes through receptor-dependent or independent intracellular mechanisms, as well as functional changes caused by the selective serotonylation of target proteins.

We look forward to receiving your contributions.

Dr. Iván P. Uray
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • serotonin
  • 5-HT
  • cancer
  • carcinogenesis
  • invasion
  • tumor microenvironment
  • serotonylation
  • mechanotransduction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop